In addition, a recent study discovered that low-dose IL-34 regulated hBMSCs osteogenesis and enhanced fracture healing in part via the PIK/AKT and ERK signaling pathways but had no effect on osteoclast formation in vitro or osteoporosis in vivo (106). This evidence concerns the gene AKT1 and osteoporosis.